Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Extel 2010

16 Jun 2010 09:19

RNS Number : 6983N
Arden Partners plc
16 June 2010
 



Arden Partners plc

("Arden" or the "Company")

Arden Partners, the institutional stockbroker, is delighted that its equity brokerage and research teams ranked highly in Extel's 2010 UK Survey. 

Fund managers voted Arden No. 1 for broking Financials (Jeremy Grime, Sarah Spikes, Peter Lenardos) and No. 3 for broking Capital Goods (Ben Thefaut, Chris Thomas, David Larkam, and Graham Webster).

Individually, Jeremy Grime and Sarah Spikes were voted the No. 1 and No. 2 analysts in Financials.

Extel 2010 is based on record participation across the professional investment community, with data and processes independently verified by Deloitte.

Commenting on the result, Jonathan Keeling, CEO of Arden said;

"We are delighted that our teams and individuals have been recognised by the buy-side community at these awards. We have a strong capability in our research department across our specialist sectors and these awards demonstrate our commitment to recruiting and retaining quality analysts and salespeople to provide leading insightful analysis."

For further information, please contact:

 

Arden Partners plc 020 7614 5900

Jonathan Keeling - Chief Executive Officer

 

Buchanan Communications 020 7466 5000

Mark Edwards / Nicola Cronk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGGUBGQUPUURQ
Date   Source Headline
10th Feb 201110:04 amRNSForm 8.5 (EPT/NON-RI)
10th Feb 201110:02 amRNSForm 8.5 (EPT/NON-RI)
9th Feb 20114:28 pmRNSHolding(s) in Company
9th Feb 20114:28 pmRNSDirectors' Dealings
9th Feb 20114:27 pmRNSTransaction in own shares/Exercise of options/TVR
9th Feb 20119:32 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20119:17 amRNSForm 8.5 (EPT/NON-RI)
4th Feb 201110:36 amRNSForm 8.5 (EPT/NON-RI)
3rd Feb 201110:45 amRNSForm 8.5 (EPT/NON-RI)
2nd Feb 201110:09 amRNSForm 8.5 (EPT/NON-RI)
2nd Feb 201110:07 amRNSForm 8.5 (EPT/NON-RI)
1st Feb 20113:55 pmRNSTotal Voting Rights
1st Feb 201111:41 amRNSForm 8.5 (EPT/NON-RI)
1st Feb 201111:29 amRNSForm 8.5 (EPT/NON-RI)
27th Jan 20119:25 amRNSForm 8.5 (EPT/NON-RI)
27th Jan 20119:19 amRNSForm 8.5 (EPT/NON-RI)
25th Jan 20119:25 amRNSForm 8.5 (EPT/NON-RI)
25th Jan 20119:23 amRNSForm 8.5 (EPT/NON-RI)
24th Jan 201110:31 amRNSForm 8.5 (EPT/NON-RI)
21st Jan 20119:26 amRNSForm 8.5 (EPT/NON-RI)
20th Jan 20119:52 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 201111:17 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 201111:16 amRNSForm 8.5 (EPT/NON-RI)
18th Jan 20112:45 pmRNSForm 8.5 (EPT/NON-RI)
18th Jan 20117:00 amRNSPreliminary results
17th Jan 201111:01 amRNSForm 8.5 (EPT/NON-RI)
14th Jan 20119:25 amRNSForm 8.5 (EPT/NON-RI)
13th Jan 20119:34 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 20119:49 amRNSForm 8.5 (EPT/NON-RI)
11th Jan 20119:18 amRNSForm 8.5 (EPT/NON-RI)
7th Jan 201110:18 amRNSForm 8.5 (EPT/NON-RI)
6th Jan 20119:25 amRNSForm 8.5 (EPT/NON-RI)
31st Dec 20109:37 amRNSForm 8.5 (EPT/NON-RI)
30th Dec 201010:42 amRNSForm 8.5 (EPT/NON-RI)
24th Dec 201010:31 amRNSForm 8.5 (EPT/NON-RI)
23rd Dec 201011:03 amRNSChange of results announcement date
22nd Dec 20107:00 amRNSBoard changes
17th Dec 20109:25 amRNSForm 8.5 (EPT/NON-RI)
16th Dec 201011:36 amRNSForm 8.5 (EPT/NON-RI)
10th Dec 201010:00 amRNSDirector's declaration
10th Dec 20107:00 amRNSBoard change
7th Dec 201011:28 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 201011:38 amRNSForm 8.5 (EPT/NON-RI)
22nd Nov 20107:02 amRNSTotal Voting Rights
22nd Nov 20107:00 amRNSBlocklisting Return
15th Nov 20103:14 pmRNSHolding(s) in Company
12th Nov 20103:29 pmRNSHolding(s) in Company
12th Nov 20107:00 amRNSDirectors dealings
10th Nov 20104:30 pmRNSHolding(s) in Company
10th Nov 20104:19 pmRNSDirector's Holding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.